Encube Ethicals Private Limited — Soframycin Exporter Profile
Indian Pharmaceutical Exporter · #1 for Soframycin · $473.5K export value · DGFT Verified
Encube Ethicals Private Limited is the #1 Indian exporter of Soframycin with $473.5K in export value and 19 verified shipments. Encube Ethicals Private Limited holds a 79.1% market share in Soframycin exports across 3 countries. The company exports 11 pharmaceutical products worth $57.5M across 9 therapeutic categories.
Encube Ethicals Private Limited — Soframycin Export Profile: Buyers & Destinations
Where Does Encube Ethicals Private Limited Export Soframycin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| SRI LANKA | $306.6K | 16 | 99.9% |
| SWEDEN | $158 | 1 | 0.1% |
| GERMANY | $122 | 2 | 0.0% |
Encube Ethicals Private Limited exports Soframycin to 3 countries. The largest destination is SRI LANKA accounting for 99.9% of Encube Ethicals Private Limited's Soframycin shipments, followed by SWEDEN (0.1%) and GERMANY (0.0%). These destinations reflect Encube Ethicals Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Soframycin from Encube Ethicals Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| A. BAUR & CO. (PVT.) LTD | SRI LANKA | $156.6K | 11 |
| A BAUR CO PRIVATE LIMITED | SRI LANKA | $100.0K | 3 |
| A BAUR AND CO PVT LTD | SRI LANKA | $50.0K | 2 |
| NORDEN MACHINERY AB | SWEDEN | $280 | 3 |
Encube Ethicals Private Limited supplies Soframycin to 4 buyers globally. The largest buyer is A. BAUR & CO. (PVT.) LTD (SRI LANKA), followed by A BAUR CO PRIVATE LIMITED (SRI LANKA) and A BAUR AND CO PVT LTD (SRI LANKA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Soframycin Export Value and How Much Does Encube Ethicals Private Limited Contribute?
India exported $506.1K worth of Soframycin through 243 shipments from 63 suppliers to 36 countries, serving 95 buyers globally. Encube Ethicals Private Limited contributes $473.5K to this total, accounting for 79.1% of India's Soframycin exports. Encube Ethicals Private Limited ships Soframycin to 3 countries through 4 buyers.
What Is the Average Shipment Value for Encube Ethicals Private Limited's Soframycin Exports?
Encube Ethicals Private Limited's average Soframycin shipment value is $24.9K per consignment, based on 19 shipments totaling $473.5K. The largest destination is SRI LANKA (99.9% of Encube Ethicals Private Limited's Soframycin exports).
How Does Encube Ethicals Private Limited Compare to Other Indian Soframycin Exporters?
Encube Ethicals Private Limited ranks #1 among 63 Indian Soframycin exporters with a 79.1% market share. The top 3 exporters are ENCUBE ETHICALS PRIVATE LIMITED ($473.5K), CAPSTONE EXPORT & IMPORT ($18.8K), S. HIMATLAL HEALTHCARE LLP ($11.4K). Encube Ethicals Private Limited processed 19 shipments to 3 destination countries.
What Soframycin Formulations Does Encube Ethicals Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| SOFRAMYCIN CREAM 20GM TUBE BATCH NO.4CH236,4CH237 MFG DT.MAR 2024 EXP DT. AUG 2026,4CH238,4CH239 MFG DT.ARP 2024 EXP DT. | $100.3K | 3 |
| SOFRAMYCIN CREAM 20GM TUBE BATCH No 3CH65 TO 3CH67 MFG DT FEB 2023 EXP DT JUL 2025 | $50.0K | 1 |
| SOFRAMYCIN CREAM 20GM TUBE BATCH No.3CH | $50.0K | 1 |
| SOFRAMYCIN CREAM 20GM TUBE B.NO.3CH302 , | $50.0K | 1 |
| SOFRAMYCIN CREAM 20GM TUBE B.NO.G5CH86,G5CH87, G5CH88, G5CH89 MFG DT.JAN 2025EXP DT.JUN 2027 | $50.0K | 1 |
| SOFRAMYCIN CREAM 20GM TUBE B.NO. 4CH550MFG DT.OCT 2024 EXP DT.MAR 2027 & G5CH89A MFG DT.JAN 2025 EXP DT.JUN 2027 | $6.3K | 2 |
| Placebo of Soframycin Cream | $158 | 1 |
| SOFRAMYCIN CREAM- PLACEBO | $122 | 2 |
| SOFRAMYCIN CREAM 20GM TUBE B.NO. G5CH89A MFG DT.JAN 2025 EXP DT.JUN 2027 | $3 | 2 |
| SOFRAMYCIN CREAM 20GM TUBE BATCH No 3CH68 MFG DT FEB 2023 EXP DT JUL 2025 FREETRADE SAMPLE NO COMMERCIAL VALUE | $0 | 1 |
Encube Ethicals Private Limited exports 12 distinct Soframycin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is SOFRAMYCIN CREAM 20GM TUBE BATCH NO.4CH236,4CH237 MFG DT.MAR with 3 shipments worth $100.3K.
Regulatory Requirements: Exporting Soframycin to Key Markets
What Encube Ethicals Private Limited must comply with to export Soframycin to its top destination countries
Germany — BfArM/EMA
Approval Process
Marketing Authorisation via Decentralized or Mutual Recognition Procedure under EU Directive 2001/83/EC. CTD Module 1–5 dossier required.
Timeline: 12–18 months via Decentralized Procedure
GMP & Export Requirements
EU GMP (EudraLex Vol. 4); GMP certificate from EU competent authority; WHO Prequalification accepted as supporting evidence
Certificate of Pharmaceutical Product (CPP) from CDSCO; Written Confirmation for API export per EU requirements; EU FMD serialization mandatory
Note: Indian manufacturers must hold EU GMP certificate. EU Falsified Medicines Directive (FMD) serialization and tamper-evident packaging mandatory.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Encube Ethicals Private Limited Compare to Nearest Soframycin Exporters?
Exporters ranked immediately above and below #1 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | ENCUBE ETHICALS PRIVATE LIMITED ★ | $473.5K | 19 | 3 | $24.9K |
| 2 | CAPSTONE EXPORT & IMPORT | $18.8K | 10 | 1 | $1.9K |
| 3 | S. HIMATLAL HEALTHCARE LLP | $11.4K | 16 | 1 | $711 |
Encube Ethicals Private Limited ranks #1 among 63 Indian Soframycin exporters. Average shipment value of $24.9K compared to the market average of $8.0K. The closest competitors by value are CAPSTONE EXPORT & IMPORT and S. HIMATLAL HEALTHCARE LLP.
Which Indian Ports Ship Soframycin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 54 | 22.2% |
| SAHAR AIR CARGO ACC (INBOM4) | 44 | 18.1% |
| CHENNAI AIR | 18 | 7.4% |
| CHENNAI AIR CARGO ACC (INMAA4) | 17 | 7.0% |
| Bombay Air | 16 | 6.6% |
| JNPT/ NHAVA SHEVA SEA | 15 | 6.2% |
| NHAVA SHEVA SEA (INNSA1) | 14 | 5.8% |
| JNPT | 6 | 2.5% |
Geopolitical & Trade Policy Impact on Encube Ethicals Private Limited's Soframycin Exports
Encube Ethicals' export operations are influenced by a complex interplay of geopolitical events and international trade policies. The ongoing Israel-Iran tensions have led to increased security risks in the Red Sea, prompting major shipping lines to implement 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU. This escalation in shipping costs directly impacts Indian pharmaceutical exporters like Encube, potentially eroding profit margins and necessitating strategic adjustments in logistics and pricing strategies.
Conversely, the U.S.-China trade tensions have created opportunities for Indian pharmaceutical companies to capture a larger share of the U.S. market. Encube, with its FDA-approved facilities and established presence in the U.S., is well-positioned to leverage this shift. Additionally, the India-European Union Free Trade Agreement (FTA), concluded in January 2026, aims to eliminate tariffs on pharmaceuticals, thereby enhancing market access for Indian exporters. However, compliance with the EU's stringent regulatory standards, including the Falsified Medicines Directive, remains a critical factor for success in this market.
Encube Ethicals Private Limited — Regulatory Compliance & Quality Standards
Maintaining compliance with international regulatory standards is paramount for Encube Ethicals. The company's adherence to FDA, WHO, and EU Good Manufacturing Practices (GMP) ensures the quality and safety of its products, facilitating access to global markets. The evolving regulatory landscape, particularly in the EU, necessitates continuous investment in quality systems and processes. For instance, the EU's requirement for analytical testing of every batch at the port of destination can delay market entry by two to three months. Proactive engagement with regulatory bodies and investment in compliance infrastructure are essential for mitigating such challenges.
About Encube Ethicals Private Limited
Encube Ethicals Private Limited exports 11 products worth $57.5M. Beyond Soframycin, top products include Clindamycin, Diclofenac, Clotrimazole, Ketoconazole, Sodium. View the complete Encube Ethicals Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Soframycin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Soframycin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Encube Ethicals Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 19 individual customs records matching Encube Ethicals Private Limited exporting Soframycin, covering 12 formulations to 3 countries via 4 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 36+ countries, 95+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Soframycin Export Data from Encube Ethicals Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Encube Ethicals Private Limited's Soframycin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Encube Ethicals Private Limited
Full Company Profile →
11 products · $57.5M total trade · 9 categories
Soframycin Stats
Company Overview
Top Products by Encube Ethicals Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Encube Ethicals Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Soframycin. For current shipment-level data, contact TransData Nexus.